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Objective: To test the hypothesis that the size of a juxtaluminal black (hypoechoic) area (JBA) in ultrasound images of
asymptomatic carotid artery plaques predicts future ipsilateral ischemic stroke.
Methods: A JBA was deﬁned as an area of pixels with a grayscale value <25 adjacent to the lumen without a visible
echogenic cap after image normalization. The size of a JBA was measured in the carotid plaque images of 1121 patients
with asymptomatic carotid stenosis 50% to 99% in relation to the bulb (Asymptomatic Carotid Stenosis and Risk of
Stroke study); the patients were followed for up to 8 years.
Results: The JBA had a linear association with future stroke rate. The area under the receiver-operating characteristic
curve was 0.816. Using Kaplan-Meier curves, the mean annual stroke rate was 0.4% in 706 patients with a JBA <4 mm2,
1.4% in 171 patients with a JBA 4 to 8 mm2, 3.2% in 46 patients with a JBA 8 to 10 mm2, and 5% in 198 patients with
a JBA >10 mm2 (P < .001). In a Cox model with ipsilateral ischemic events (amaurosis fugax, transient ischemic attack
[TIA], or stroke) as the dependent variable, the JBA (<4 mm2, 4-8 mm2, >8 mm2) was still signiﬁcant after adjusting for
other plaque features known to be associated with increased risk, including stenosis, grayscale median, presence of discrete
white areas without acoustic shadowing indicating neovascularization, plaque area, and history of contralateral TIA or
stroke. Plaque area and grayscale median were not signiﬁcant. Using the signiﬁcant variables (stenosis, discrete white
areas without acoustic shadowing, JBA, and history of contralateral TIA or stroke), this model predicted the annual risk
of stroke for each patient (range, 0.1%-10.0%). The average annual stroke risk was <1% in 734 patients, 1% to 1.9% in
94 patients, 2% to 3.9% in 134 patients, 4% to 5.9% in 125 patients, and 6% to 10% in 34 patients.
Conclusions: The size of a JBA is linearly related to the risk of stroke and can be used in risk stratiﬁcation models. These
ﬁndings need to be conﬁrmed in future prospective studies or in the medical arm of randomized controlled studies in the
presence of optimal medical therapy. In the meantime, the JBA may be used to select asymptomatic patients at high stroke
risk for carotid endarterectomy and spare patients at low risk fromanunnecessary operation. (JVasc Surg2013;57:609-18.)Risk stratiﬁcation for stroke in patients with asymptom- include the severity of stenosis,1 echolucent (hypoechoic)
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610 Kakkos et al March 2013Histologic studies showed that the necrotic core is
twice as close to the lumen in unstable, symptomatic
plaques compared with asymptomatic plaques.9 These ﬁnd-
ings correspond to subsequent observations made in cross-
sectional studies using ultrasound scanning, showing an
association between the juxtaluminal black (hypoechoic)
area (JBA) and the presence of neurologic symptoms in
the patient.10-12 A JBA in ultrasound images of asymptom-
atic carotid artery plaques is associated with a lipid core
close to the lumen on histologic examination of carotid
endarterectomy specimens.13 A cross-sectional study of
patients with symptomatic and asymptomatic plaques by
our group has demonstrated that a JBA >8 mm2 in the
absence of a visible echogenic cap was associated with
a high prevalence of symptomatic plaques in all grades of
stenosis.10
Despite the previously mentioned evidence from cross-
sectional studies, the prognostic role of the JBA in longitu-
dinal studies of asymptomatic carotid artery stenosis and its
contribution to risk stratiﬁcation remain unknown. We
previously suggested that cutoff points from cross-sectional
studies need to be validated in prospective studies of asymp-
tomatic patients.10
The Asymptomatic Carotid Stenosis and Risk of Stroke
(ACSRS) study was a multicenter longitudinal study of
patients with asymptomatic carotid stenosis managed
conservatively. The aim of our study was to test the hypoth-
esis that the presence and size of a JBA in the absence of
a visible echogenic cap predicts future ipsilateral ischemic
stroke in this cohort of patients.METHODS
Patient recruitment. Inclusion and exclusion criteria
and recruitment sources have been previously reported in
detail.6 Brieﬂy, newly referred patients with 50% to 99%
internal carotid artery stenosis in relation to the carotid
bulb diameter (European Carotid Surgery Trial [ECST]
method) without previous ipsilateral cerebral or retinal
ischemic (CORI) symptoms and without neurologic
abnormality were eligible for inclusion; these patients were
recruited to the study after they provided written informed
consent. Patients who had contralateral cerebral hemi-
spheric or retinal or vertebrobasilar symptoms or signs of
stroke or transient ischemic attack (TIA) were included if
they were asymptomatic for at least 6 months before
recruitment. For patients with bilateral asymptomatic
carotid atherosclerosis, the side with the more severe
stenosis was considered ipsilateral (the study artery).
Patients who could not attend for 6 monthly neurologic
assessments and patients with a limited life expectancy
because of conditions such as severe cardiac failure or
disseminated malignancy were excluded. Approval was
obtained from the Multicenter Research Ethics Committee
(North Thames, London, United Kingdom) and local
ethics committees.
Clinical and biochemical characteristics. Clinical and
biochemical characteristics have been published previously.6Duplex examination. Carotid duplex scanning was
performed on admission to the study. Ultrasonographers
from all centers attended a 1-day training course on
equipment settings, image capture, and use of velocity
criteria at the coordinating center. The duplex examina-
tion, recorded on S-VHS videotape, was sent to the
coordinating center for quality control. As previously
described, a combination of velocity criteria was used to
express the degree of stenosis in terms of the ECST
method and the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) method.1,6,14 Although
velocities and both ECST and NASCET stenoses were
available for every patient, ECST stenosis was used in the
analysis because of its linear relationship to the risk of
ipsilateral CORI events, in contrast to NASCET stenosis,
which has an S-shaped relationship.1 Contralateral internal
carotid artery occlusion was noted. Bilateral vertebral artery
ﬂow was reported as cephalad, reversed, or not visualized.
Image acquisition of carotid plaques. As reported
previously,6,15 several prerequisites essential for successful
image normalization were applied during duplex image
acquisition, as follows:
1. Maximum dynamic range was used that ensured the
greatest possible display of grayscale values and
texture detail.
2. Persistence was set on low and frame rate was set on
high, the latter ensuring good temporal resolution.
3. The time gain compensation curve was sloping
through the tissues but was positioned vertically
through the lumen of the vessel because the ultra-
sound beam was not attenuated as it passed through
blood; this ensured that the adventitia of the anterior
and posterior walls had similar brightness.
4. The overall gain was adjusted to give optimal image
quality; this was achieved by adjustment of the gain
control to minimize, but not abolish, noise. In prac-
tice, the gain was turned down so that noise was
abolished and then gradually increased until some
noise appeared in the lumen; this ensured that low-
intensity features in the plaque were not lost and
that there was a black area without noise in the
lumen to be used for normalization.
5. A linear postprocessing curve was used. In the
absence of a linear curve, a curve closest to linear
was used.
6. The ultrasound beam was at 90 degrees to the arte-
rial wall.
7. The minimum depth was used so that the plaque
occupied a large part of the image.
8. The position of the probe was adjusted so that adven-
titia adjacent to the plaquewas clearly visible as a hyper-
echoic band and could be used for normalization.
Image normalization and analysis. Baseline images
from video recordings were digitized ofﬂine on a PC
using a video grabber card (Videologic, TV Snap version
1.0.3; Play Inc, Rancho Cordova, Calif) at a resolution of
Fig 1. A, Normalized grayscale image of the origin of the internal carotid artery (ICA) showing an apparently
hyperechoic plaque. B, Color ﬂow image of the same plaque showing the jet of blood at the tightest part of the stenosis
(90%-95% North American Symptomatic Carotid Endarterectomy Trial method) and a juxtaluminal black (hypoechoic)
area (JBA) as a ﬁlling defect on the far wall component of the plaque. C, Segmented grayscale image of the same plaque
before and after color contouring according to the gray level of pixels (grayscale: 0-25 ¼ black; 26-50 ¼ blue;
51-75 ¼ green; 76-100 ¼ yellow; 101-125 ¼ orange; $125 ¼ red). The larger JBA of the far wall component of the
plaque measures 13.6 mm2. The larger JBA of the near wall component of the plaque measures 2.7 mm2.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 3 Kakkos et al 611640  480 pixels at the coordinating center by two
members of the team who were experienced in carotid
scanning. Image normalization for grayscale using linear
scaling with “blood” (grayscale ¼ 0) and adventitia
(grayscale ¼ 190)16 and pixel density standardization
to 20 pixels/mm were performed followed by image
analysis of the plaque outline. The exact plaque outline
was determined with the aid of the color Doppler
video clip from which a representative single image
was selected. The Plaque Texture Analysis software
version 4 (Iconsoft International Ltd, Greenford,
London, United Kingdom) was used.15 Plaque texture
features that were automatically calculated using the
Feature Extraction module of the software included GSM
and plaque area using the on-screen millimeter scale from
each ultrasonic image.6,15 The presence of DWAs
without acoustic shadowing was identiﬁed visually after
image normalization.6 The JBA without a visible echo-
genic cap was assessed as previously described.10 Brieﬂy,
the largest JBA of the contoured image (ie, area with
pixels having a grayscale value <25) without a visible
echogenic cap (ie, pixels with grayscale value >25) wasoutlined using the cursor. The JBA area was automati-
cally calculated by the software and expressed as square
millimeters (Fig 1).10 The larger value was used in cases
where there were two plaque components with black
areas. Reproducibility of the JBA measurement has been
previously reported.10
Follow-up. Patient follow-up was conducted every
6 months to perform a repeat Duplex examination, as
described earlier, and to record clinical events (see later).
Outcome measures. The primary outcome measure
(end point) of the current report was ipsilateral cerebral
ischemic stroke (fatal or nonfatal). Stroke was deﬁned as
a cerebral deﬁcit most likely of vascular origin lasting
>24 hours. For each stroke, details recorded by the local
neurologist, a 6-month modiﬁed Rankin score, and
computed tomography or magnetic resonance imaging
(MRI) brain scan results were requested. Two coordinating
center members including a neurologist made the ﬁnal
classiﬁcation of the primary outcome measure. CORI
events were considered as secondary outcomes.
Study exit points. Follow-up ceased with the ﬁrst
occurrence of any of the following: the ﬁrst CORI event,
Fig 2. Kaplan-Meier plots showing ipsilateral cerebrovascular or
retinal ischemic (CORI) event–free survival (A) and stroke-free
survival (B), stratiﬁed by juxtaluminal black (hypoechoic) area
(JBA). Standard error bars are shown for each curve; the number of
patients at risk at each interval is shown at the bottom of each graph.
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angioplasty and stenting for the still-asymptomatic study
artery; death from causes other than ipsilateral stroke; or
loss to follow-up. Carotid endarterectomy or angioplasty
and stenting were not included in the CORI events. Also,
stroke associated with carotid intervention for the still-
asymptomatic study artery was not included in event rate
calculations.
Statistical analysis. Receiver-operating characteristic
(ROC) curves for the JBA were constructed with stroke
as the state variable, and the area under the curve was esti-
mated. The JBA was categorized and used for stratiﬁed
Kaplan-Meier plots, which were compared with the log-
rank test. For this purpose, several cutoff points were
tested, including a previously suggested cutoff point
(8 mm2) based on a cross-sectional study. Subsequently,
the JBA was entered into a multivariate proportional
hazards model with CORI events or stroke as the depen-
dent variable, together with other plaque features known
to be associated with increased risk (stenosis, GSM, pres-
ence of DWA indicating neovascularization, plaque area,
and history of contralateral TIA or stroke).6 The associa-
tion between the JBA and stenosis grade was tested with
Pearson correlation. Statistical analysis was performed with
PASW/SPSS Statistics 18 or later (SPSS Inc, Chicago, Ill),
and survival plots were created with Prism 6 for Windows
(GraphPad Software, Inc, La Jolla, Calif).
RESULTS
The study included 1121 patients 39 to 89 years old
(mean age, 70.0 years; standard deviation, 7.7; 61%
men), recruited from 1998 to 2002 with a follow-up of
6 to 96 months (mean, 48 months), as previously re-
ported.6 During patient follow-up, 130 ﬁrst ipsilateral
CORI events occurred (59 strokes, of which 12 were fatal;
49 TIAs; and 22 amaurosis fugax episodes). The associa-
tion between baseline clinical, biochemical, and ultrasound
baseline features associated with the development of CORI
events and stroke has been previously reported.6
Ipsilateral cerebrovascular events. Using Kaplan-
Meier curves, the 5-year CORI event rate was 3% in
706 patients with a JBA<4 mm2, 21% in 171 patients with a
JBA 4 to 8mm2, 36% in 46 patients with a JBA 8 to 10mm2,
and 43% in 198 patients with JBA >10 mm2 (P < .001)
(Fig 2, A). The corresponding average annual rates (mean at
5 years) were 0.6%, 4.2%, 7.2%, and 8.6%.
In a multivariate analysis using Cox proportional-
hazards regression with ipsilateral CORI events (amaurosis
fugax, TIA, or stroke) as the dependent variable, the JBA
(<4 mm2, 4-8 mm2, >8 mm2) was still signiﬁcant after
adjusting for other plaque features known to be associated
with increased risk, including stenosis, GSM, presence of
DWA, plaque area, and history of contralateral TIA or
stroke (Table, Model A).6 Plaque area and GSM were
not signiﬁcant. JBA and percent stenosis were poorly corre-
lated (Pearson correlation coefﬁcient r ¼ 0.083).
Ipsilateral stroke. The JBAhad a linear associationwith
future stroke rate. Using Kaplan-Meier curves, the 5-yearstroke rate was 2% in 706 patients with a JBA <4 mm2,
7% in 171 patients with a JBA 4 to 8 mm2, 16% in
46 patients with a JBA 8 to 10 mm2, and 25% in 198 patients
with JBA>10mm2 (P< .001) (Fig 2,B). The corresponding
average annual rates (mean at 5 years) were 0.4%, 1.4%, 3.2%,
and 5%.
The area under theROCcurve for stroke using the JBA as
a continuous variable was 0.816 (95% conﬁdence interval
[CI], 0.77-0.86; P < .001). Of the 59 ipsilateral ischemic
strokes, 42 (71%) occurred in the 244 patients (22% of the
cohort) who had a JBA of $8 mm2 (P < .001) (Fig 3, A).
A JBA >8 mm2 was also able to identify the patients who
were likely to develop a fatal stroke. Fatal stroke occurred in
0.2% (2/877) of patients with a JBA <8 mm2 and in 4.1%
(10/244)with a JBA$8mm2 (P< .001, using Fisher’s exact
test; odds ratio, 18.7; 95% CI, 4.1-85.9). At 8 years, fatal
stroke-free survival was 90.1% in patients with a JBA
$8 mm2 and 99.5% in patients with a JBA <8 mm2
(P < .001; hazard ratio, 19.6; 95% CI, 4.3-89.6) (Fig 3, B).
Multivariate analysis was subsequently performed using
Cox proportional-hazards regression, with ipsilateral stroke
Table. Cox proportional hazards models including JBA and other plaque features known to be associated with increased
riska
Variable b HR 95% CI P
Model A
JBA (<4, 4-8, 8-10, >10 mm2) 0.816 2.26 1.84-2.78 <.001
Stenosis (50-69, 70-89, 90-99%) 0.241 1.27 0.98-1.66 .073
DWA (present, absent) 0.883 2.42 1.52-3.85 <.001
History of contralateral TIA or stroke (present, absent) 0.518 1.68 1.14-2.47 .008
GSM (<15, 15-30, >30) 0.041 0.96 0.72-1.27 .776
Plaque area (<40, 40-80, >80 mm2) 0.099 1.04 0.83-1.47 .502
Model B
JBA (4, 4-8, 8-10, >10 mm2) 0.773 2.16 1.58-2.97 <.001
Stenosis (50-69, 70-89, 90-99%) 0.465 1.59 1.06-2.38 .025
DWA (present, absent) 0.619 1.86 0.98-3.51 .057
History of contralateral TIA or stroke (present, absent) 0.793 2.21 1.28-3.61 .004
GSM (<15, 15-30, >30) 0.163 1.18 0.75 to 1.83 .471
Plaque area (<40, 40-80, >80 mm2) 0.051 1.05 0.68-1.62 .818
Model C
JBA (4, 4-8, 8-10, >10 mm2) 0.853 2.34 1.89-2.91 <.001
Stenosis (50-69, 70-89, 90-99%) 0.462 1.59 1.06-2.37 .023
DWA (present, absent) 0.582 1.90 0.98-3.27 .059
History of contralateral TIA or stroke (present, absent) 0.788 2.20 1.27-3.79 .005
CI, Conﬁdence interval; DWA, discrete white areas; GSM, grayscale median; HR, hazard ratio; JBA, juxtaluminal black (hypoechoic) area; TIA, transient
ischemic attack.
aStenosis, GSM, presence of DWAs without acoustic shadowing indicating neovascularization, plaque area, and history of contralateral TIA or stroke, with
ipsilateral cerebral or retinal ischemic events as the dependent variable in model A and ipsilateral ischemic stroke as the dependent variable in models B and C.
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was still signiﬁcant after adjusting for other plaque features
known tobe associatedwith increased risk, including stenosis,
GSM, presence ofDWA, plaque area, andhistory of contralat-
eral TIA or stroke (Table, Model B).6
Using the signiﬁcant variables (stenosis, DWA, JBA,
and history of contralateral TIA or stroke) in the Cox
model C (Table, Model C), the 5-year stroke-free survival
(not shown) and average annual risk of stroke were calcu-
lated for each patient. Subsequently, patients were grouped
in ﬁve subgroups of annual stroke risk (<1.0, 1.0-1.9, 2.0-
3.9, 4.0-5.9, and $6) (Fig 4, A-C). The annual stroke risk
was <1% in 722 patients, 1% to 1.9% in 110 patients, 2% to
3.9% in 162 patients, 4% to 5.9% in 70 patients, and 6% to
10% in 57 patients.
DISCUSSION
This is the ﬁrst study to demonstrate that the size of the
JBA on ultrasound scan can be used in risk stratiﬁcation
models to calculate the risk for individual patients with
asymptomatic carotid artery stenosis. The initial observa-
tion, which probably led to the development of JBA deter-
mination on ultrasound, was reported in a histologic study
that showed carotid plaques causing symptoms were associ-
ated with a more frequent juxtaluminal location of the lipid
core compared with asymptomatic carotid plaques.9 Subse-
quently, the JBA was studied in carotid plaque images
obtained with ultrasound scanning and was found to occur
more frequently in symptomatic than asymptomatic
plaques.11 Additionally, an absent, thin, or ruptured
echogenic cap has been observed more frequently in carotid
plaques causing cerebrovascular symptoms or cerebralinfarction on ultrasound scan or MRI.17,18 However, the
JBA and echogenic cap determination was subjective in
this early research because computer or scanner monitor
brightness can alter the results of visual assessment, including
the extension of plaque.19 It became obvious at that time
that standardization of this new ultrasound feature using
objective methodology was necessary. Subsequently, image
normalization and color mapping were employed in JBA
determination13 so that echolucent areas near the plaque
lumen could become well deﬁned with reproducible
measurements of their area, without the aforementioned
disadvantages of visual assessment.19 Finally, the use of the
corresponding color Doppler image and the video clip of
the duplex examination in cases of hypoechoic plaques is
of paramount importance for the accurate determination
of the extension of the JBA and the precise estimation of
its size, without inclusion of luminal areas that can falsely
increase its size.
Stratiﬁed GSM is another relative technique aiming to
identify juxtaluminal echolucent plaque components13;
however, this technique considers all pixels at a certain
distance from the luminal surface and is unsuitable to esti-
mate regional plaque characteristics. A reﬁnement of this
method was published more recently that calculates the
proportion of echolucent pixels within the most superﬁcial
0.5 mm of the plaque surface and a derivative score (risk
index) that additionally takes into account severity of
stenosis.20 Our group advanced JBA determination further
not only by estimating its size and determining the best
cutoff point in a cross-sectional study but also excluding
plaques with a clearly visible echogenic cap, a surrogate
end point of plaque stability.10 In symptomatic unstable
Fig 3. Kaplan-Meier plots showing ipsilateral ischemic stroke-free
survival (A) and fatal stroke–free survival (B), stratiﬁed by a jux-
taluminal black (hypoechoic) area (JBA) size of 8 mm2. Standard
error bars are shown for each curve; the number of patients at risk
at each interval is shown at the bottom of each graph.
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0.2 mm compared with 0.4 mm for asymptomatic plaques.9
We hypothesized that because resolution of ultrasound in
carotid images is 0.2 mm, ﬁbrous caps thinner than
0.2 mm are unlikely to be visualized. Alternative explana-
tions could be that the plaque has already ruptured or the
hypoechoic area is a thrombus overlying the plaque. What-
ever the explanation, all of the above-mentioned possibilities
are dangerous. Further support to our hypothesis is provided
not only from our results but also from previous studies,
which have shown good agreement between carotid ultra-
sound scanning and plaque histology.21,22 In addition, it
has been shown that the presence of a thin or ruptured
ﬁbrous cap on carotid MRI in patients with moderate
asymptomatic stenosis is a strong predictor of future neuro-
logic events.23 Also, in patients with TIAs and carotid
plaques causing mild to moderate stenosis, the presence of
juxtaluminal hemorrhage or thrombus on MRI is a strong
predictor of TIA recurrence.24
Whether stratiﬁed GSM and risk index are better than
JBA size determination in predicting future neurologic
events including stroke in patients with asymptomatic
carotid stenosis remains to be clariﬁed. In cross-sectionalstudies, however, odds ratios for risk index and JBA size in
discriminating symptomatic from asymptomatic plaques
were 4.89 and 6.7.10,20
In the present study, we demonstrated for the ﬁrst time
that the presence of a JBA without a visible echogenic cap
was associated with the occurrence of future ipsilateral
neurologic events in patients with asymptomatic carotid
artery stenosis; this association was still signiﬁcant after
adjustment for known predictors in multivariate analysis.
Although JBA was associated with the presence of ipsilateral
carotid symptoms in two previous studies,11,25 the cross-
sectional nature of these studies precluded the ﬁndings
from risk assessment modeling, and longitudinal studies
such as ACSRS were necessary.
Our study also showed that the size of a JBA was a very
strong predictor of stroke, with the area under the ROC
curve being 0.816; a linear association with stroke rate rein-
forces the value of this feature. Additionally, the ﬁnding
that not only neurologic events as a whole, but also ispilat-
eral ischemic stroke, a hard end point, is associated with
JBA size increases the validity of our results. Plaques with
a small or nonmeasurable JBA (#1 mm2) were associated
with a minimal stroke risk (1/330; 0.3%).
An association between fatal stroke and JBAwas demon-
strated by the current investigation. A possible explanation is
that a large JBA capable of producing a large ulcer of the
carotid surface that can produce a large embolus can lead
to a large brain infarct and more often to a fatal stroke.
We have previously shown that the severity of stenosis,
a history of contralateral TIA or stroke (indicative of
a systemic cause of plaque instability), and the presence
of markers of plaque vulnerability (GSM, plaque area,
and DWA without acoustic shadowing that indicate neo-
vascularization)26 can be used in risk modeling for stroke
in asymptomatic carotid stenosis.6 Our updated ﬁndings
support the concept of plaque heterogeneity, previously
shown to be predictive of neurologic events.27 A carotid
plaque with a large JBA and DWA is certainly heteroge-
neous. The difference with visual assessment is that
computerized assessment of components of heterogeneity
is objective and reproducible. Additionally, the number
of independent predictive factors has been reduced from
ﬁve in our prior report to four with our current approach,
without compromising its predictive value, as reﬂected by
the area under the ROC curve. Apart from stenosis that
everybody measures, there are only two new ultrasound
features—the JBA size and presence or absence of DWA.
After image normalization, both of these features are easy
to detect and measure regardless of the ultrasound equip-
ment used. As expected for an independent predictor on
multivariate analysis, JBA did not correlate with degree of
stenosis. We showed that 24% of plaques producing mild
stenosis (50%-69% ECST or <50% NASCET; Fig 4, C)
were also at some risk, being associated with an annual
stroke risk >1%. In support of this ﬁnding, the odds ratio
of JBA size in discriminating symptomatic from asymptom-
atic plaques is greater in less severe stenoses.10 In agree-
ment with our ﬁndings, one MRI study showed that the
History of Contralateral
TIAs or Stroke Absent
History of Contralateral
TIAs or Stroke Present
DWA
A
B
C
Present
n  =
0.8% 
101
2.0% 
39
4.1% 
8
6.2%
30
1.0% 
19
3.6%
9
7.6%
4
10.0%
8
Absent
n  =
0.6%
44
1.2%
16
3.0% 
2
3.8%
24
0.7%
14
2.6% 
2
5.2%
4
7.4%
0
< 4 4-8 8-10 ≥ 10 < 4 4-8 8-10 ≥ 10
JBA  
mm2
JBA  
mm2
Annual
Stroke
Rate 
%
≥ 6 
4.0-5.9
2.0-3.9
1.0-1.9
< 1.0 
History of Contralateral
TIAs or Stroke Absent
History of Contralateral
TIAs or Stroke Present
DWA
Present
n =
0.6%
220
1.4% 
50
2.8%
20
4.4%
44
0.8% 
25
2.6% 
7
5.8%
2
8.4%
15
Absent
n =
0.4%
129
0.9% 
19
1.4%
3
2.6%
40
0.5%
12
1.6%
1
3.4%
2
5.4%
8
< 4 4-8 8-10 ≥ 10 < 4 4-8 8-10 ≥ 10
JBA  
mm2
JBA          
mm2
Annual
Stroke
Rate 
%
≥ 6 
4.0-5.9
2.0-3.9
1.0-1.9
< 1.0 
History of Contralateral
TIAs or Stroke Absent
History of Contralateral
TIAs or Stroke Present
DWA
Present
n =
0.2% 
67
0.8%
11
1.6%
4
2.6%
10
0.4% 
11
1.6%
9
3.4% 
0
5.0%
4
Absent
n =
0.1%
49
0.4% 
8
0.9%
1
1.5%
8
0.3% 
13
1.0%
0
2.0%
0
3.3%
3
< 4 4-8 8-10 ≥ 10 < 4 4-8 8-10 ≥ 10
JBA  
mm2
JBA  
mm2
Annual
Stroke
Rate    
%
≥ 6 
4.0-5.9
2.0-3.9
1.0-1.9
< 1.0 
Fig 4. A, Stenosis 90%-99% European Carotid Surgery Trial (83%-99% North American Symptomatic Carotid
Endarterectomy Trial) (n ¼ 325) and predicted annual stroke risk. B, Stenosis 70%-89% European Carotid Surgery
Trial (50%-82% North American Symptomatic Carotid Endarterectomy Trial) (n ¼ 598) and predicted annual stroke
risk. C, Stenosis 50%-69% European Carotid Surgery Trial (<50% North American Symptomatic Carotid Endarter-
ectomy Trial) (n ¼ 198) and predicted annual stroke risk. DWA, Discrete white areas; JBA, juxtaluminal black
(hypoechoic) area; TIA, transient ischemic attack.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 3 Kakkos et al 615
JOURNAL OF VASCULAR SURGERY
616 Kakkos et al March 2013prevalence of atherosclerotic American Heart Association
type VI lesions (lesions with luminal surface defect, hemor-
rhage or thrombus, or calciﬁed nodule) in carotid arteries
with stenosis of similar severity (16%-49% using the Strand-
ness criteria) was 22%.28 In another MRI study performed
in a cohort of symptomatic and asymptomatic patients,
most unstable plaques were observed in the group with
stenosis <70% NASCET,29 whereas in a cohort of patients
with cryptogenic stroke and nonstenosing (<50%) eccen-
tric carotid plaques, American Heart Association type VI
plaques were found in 12 of 32 arteries (37.5%) ipsilateral
to the stroke.30 Although there is no trial evidence to
support intervention in this subgroup of patients with
vulnerable plaques producing mild stenosis, medical
management should probably be aggressive.
A limitation of our study, as previously discussed, was
the suboptimal medical management according to current
practice.6 Improved management is expected to reduce
event rates, and our ﬁndings need to be veriﬁed in patients
having optimal medical therapy. Another limitation was
that no assessment of optimal GSM cutoff points for
JBA determination was performed. As indicated in the
Methods section, a black area was deﬁned as an area
with gray pixel values of #25. The basis of this is that
the human eye is unlikely to distinguish shades of gray
within the range of 0 to 25 and a previously published
cross-sectional study.10 However, as far as the JBA is con-
cerned, the 8-mm2 cutoff value was found to be optimum.
Sometimes, the identiﬁcation and measurement of the
JBA is not such a straightforward process and can be
severely affected by common ultrasound limitations, such
as calciﬁcations, vessel tortuosity, and poor anatomic posi-
tioning of the vessels.
Only baseline ultrasound images obtained at entry to
the study were used for analysis in the present report. Pla-
que progression, a feature unavailable at baseline, has been
considered to be outside the scope of this study. It will be
reported subsequently.
Finally, to include the JBA in the daily clinical practice,
software such as the software used for the purpose of our
study has to be widely available, ideally as a built-in feature
of the ultrasound scanners, so that the analysis could be
carried out in <10 minutes. The software used by the
authors is widely available for use on a laptop computer
and relatively inexpensive. Surgeons from several vascular
teams referring patients to the authors’ vascular laboratory
request not only the degree of stenosis but also the risk
stratiﬁcation. Asymptomatic embolic signals by use of
transcranial Doppler have already been shown to predict
future stroke.31 Both transcranial Doppler embolic signals
and plaque echolucency have been shown to be indepen-
dent predictors of stroke, and the presence of both can
identify a subgroup with an 8% annual stroke risk.32 The
relationship between transcranial Doppler embolic signals
and the size of a JBA, whether they are independent
predictors of stroke, could be assessed in a cross-sectional
study before a possible independent association is evaluated
in longitudinal studies.CONCLUSIONS
The size of JBA is linearly related to the risk of stroke
and can be used for risk stratiﬁcation. These ﬁndings need
to be conﬁrmed in future prospective studies or in the
medical arm of randomized controlled studies in the pres-
ence of optimal medical therapy. We believe that conﬁrma-
tion of our ﬁndings will change current practice in patients
with asymptomatic carotid stenosis based on the severity of
stenosis alone. In the meantime, it may be used to select
high-risk asymptomatic patients for carotid endarterectomy
and spare many from an unnecessary operation.
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at www.jvascsurg.org.DISCUSSIONDr R. Clement Darling (Albany, NY ). Did most of your
patients start with large areas of JBA, or did you watch them
progress?
Dr Stavros K. Kakkos. These are baseline observations. We
haven’t yet analyzed the changes over time.
Dr Joy Roy (Stockholm, Sweden). I have two questions. And
the ﬁrst is, as you know, we are more restrictive in operating on
women. Did you see a difference between men and women?
Dr Kakkos. No.
Dr Roy. And the second question is, how many patients
developed a JBA during the follow-up?
Dr Kakkos. As I already explained to the moderator, we do
have the data, but it has not been analyzed yet.
Dr Mahmoud Malas (Baltimore, Md). Dr. Cambria stressed
yesterday, in his presidential speech, the importance of focusing
research on asymptomatic carotid artery stenosis. Identifying
these patients who need surgery is one of the research priorities
for our society. I am interested in the way you measured theJBA. Using ultrasound, you are looking at the JBA only in
a few angles. How did you translate that to square centimeters?
Because the only way you can really measure it accurately is by
doing either a computed tomography angiogram or a rotational
angiogram and three-dimensional reconstruction. If you could,
please elaborate a little bit more on the software that you
have used.
Dr Kakkos. To measure the size of a JBA, you need to have
a scale, and because all ultrasound images have a scale, it’s very
easy from the technical point of view to measure area. This is
a study of two-dimensional images obtained by standard ultra-
sound probes. At that time, obviously, there was no three-
dimensional ultrasound. Perhaps three-dimensional ultrasound
may perform better.
Dr Mark Fillinger (Lebanon, NH ). It appeared in your table
that there may be some colinearity between the JBA and carotid
stenosis. Did you look at the predictive power of your model
with and without the JBA to see if the area under the curve was
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618 Kakkos et al March 2013affected greatly by including JBA in the model? Does it signiﬁ-
cantly change the discriminatory power?
Dr Kakkos. Yes, it does.
Dr Robert Zwolak (Lebanon, NH ). It’s always been a bit of
a mystery why most vascular laboratories in the United States
haven’t taken up a more sophisticated approach toward carotid pla-
que analysis. I’m sure part of it has to do with the lack of additional
reimbursement, and the likelihood of added reimbursement for pla-
que analysis is very low. So if we’re going to do this in the United
States and be a bit more sophisticated about it, the technique has to
be easy, quick, reproducible, inexpensive, and scaleable. I wonder if
you would comment on each of these. How easy is this? How scale-
able is it? Is it something that could be adopted commonly across
the U.S. in many labs without much trouble?
Dr Kakkos. Ideally, this software should be part of the ultra-
sound equipment. Now, it takes 10 minutes off-line on a laptop.
If that’s going to be the case, yes, I agree it doesn’t take time, it’sscaleable, and also it would be cost-effective. Visual classiﬁcation
has certain problems, and it’s not objective. This is why there is
no reimbursement for visual classiﬁcation of echolucency or hetero-
geneity. Our technique is objective because it’s based on image anal-
ysis, which is based on the computer, not on the human eye.
DrWalter Dorigo (Florence, Italy). Do you think that the use
of enhanced contrast ultrasound can improve the visualization of
JBA and your experience with this tool?
Dr Kakkos. I do not have personal experience with contrast-
enhanced ultrasound. It could improve the results. I don’t think
that it would certainly improve visualization or identiﬁcation of
JBA, but it would ﬁnd areas within the plaque of high vasculariza-
tion that are thought to be dangerous and contribute to the iden-
tiﬁcation of a high-risk lesion. Now we think that the echogenic
areas, shown as red on the example, might represent these highly
vascularized areas, but this is a hypothesis and obviously we need
more studies.
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